Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
1987 • 64,270 citations
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
Promotion of microtubule assembly in vitro by taxol
1979 • 3,521 citations
Taxol stabilizes microtubules in mouse fibroblast cells.
1980 • 1,942 citations
A DISTRIBUTION-FREE k-SAMPLE TEST AGAINST ORDERED ALTERNATIVES
1954 • 1,455 citations
THE IMPACT OF NATIONAL CANCER ACT
1991 • 809 citations
Phase I clinical and pharmacokinetic study of taxol.
1987 • 449 citations
Use of the polymerase chain reaction in the quantitation of MDR-1 gene expression
1990 • 427 citations
Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.
1987 • 286 citations
Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines
1993 • 272 citations
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.
1993 • 244 citations
The importance of dose intensity in the outcome of chemotherapy.
1988 • 236 citations
Phase I and pharmacodynamic study of taxol in refractory acute leukemias.
1989 • 196 citations
P‐glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines
1991 • 177 citations
High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial.
1987 • 112 citations
Phase I trial of taxol given as a 3-hour infusion every 21 days.
1986 • 96 citations
Taxol administered as a 120 hour infusion
1992 • 48 citations
Current dosage and schedule issues in the development of paclitaxel (Taxol).
1993 • 46 citations
Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer.
1993 • 43 citations
Cited By (0)
No citing papers found in database